Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Bengtsson

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
EJNMMI Research|June 29, 2012
The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constantSimon-Peter Williams, Judith E Flores-Mercado, Andreas R Baudy, et al.
International Journal of Pharmaceutics|May 20, 2003
Planar gamma scintigraphy--points to consider when quantifying pulmonary dry powder aerosol depositionEva Bondesson, Thomas Bengtsson, Lars Borgström, et al.
Respiratory Medicine|October 4, 2005
Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary diseaseMalcolm Campbell, Abraham Eliraz, Gunnar Johansson, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2023
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)Antonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler, et al.
Translational Vision Science & Technology|September 25, 2020
Development of Deep Learning Models to Predict Best-Corrected Visual Acuity from Optical Coherence TomographyMichael G Kawczynski, Thomas Bengtsson, Jian Dai, et al.
American Journal of Respiratory and Critical Care Medicine|November 8, 2023
Reply to Gan <i>et al.</i>, to Calzetta <i>et al.</i>, and to PoorAntonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler, et al.
Clinical and Translational Science|February 12, 2024
Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin II type 2 receptor agonistErik Rein-Hedin, Folke Sjöberg, Cecilia Ganslandt, et al.
Neuroimage. Reports|June 26, 2025
Resting-state functional magnetic resonance imaging in a randomized clinical trial for Alzheimer's diseaseDavid Clayton, Alexandre Coimbra, Farshid Faraji, et al.
Respiratory Research|June 5, 2013
Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind studyPiotr Kuna, Yavor Ivanov, Vasily Ivanovich Trofimov, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|March 3, 2005
Dose delivery late in the breath can increase dry powder aerosol penetration into the lungsEva Bondesson, Thomas Bengtsson, Lars Borgström, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
EJNMMI Research|June 29, 2012
The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constantSimon-Peter Williams, Judith E Flores-Mercado, Andreas R Baudy, et al.
International Journal of Pharmaceutics|May 20, 2003
Planar gamma scintigraphy--points to consider when quantifying pulmonary dry powder aerosol depositionEva Bondesson, Thomas Bengtsson, Lars Borgström, et al.
Respiratory Medicine|October 4, 2005
Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary diseaseMalcolm Campbell, Abraham Eliraz, Gunnar Johansson, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2023
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)Antonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler, et al.
Translational Vision Science & Technology|September 25, 2020
Development of Deep Learning Models to Predict Best-Corrected Visual Acuity from Optical Coherence TomographyMichael G Kawczynski, Thomas Bengtsson, Jian Dai, et al.
American Journal of Respiratory and Critical Care Medicine|November 8, 2023
Reply to Gan <i>et al.</i>, to Calzetta <i>et al.</i>, and to PoorAntonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler, et al.
Clinical and Translational Science|February 12, 2024
Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin II type 2 receptor agonistErik Rein-Hedin, Folke Sjöberg, Cecilia Ganslandt, et al.
Neuroimage. Reports|June 26, 2025
Resting-state functional magnetic resonance imaging in a randomized clinical trial for Alzheimer's diseaseDavid Clayton, Alexandre Coimbra, Farshid Faraji, et al.
Respiratory Research|June 5, 2013
Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind studyPiotr Kuna, Yavor Ivanov, Vasily Ivanovich Trofimov, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|March 3, 2005
Dose delivery late in the breath can increase dry powder aerosol penetration into the lungsEva Bondesson, Thomas Bengtsson, Lars Borgström, et al.
Pageof 7